ASTH logo

Astrana Health, Inc. (ASTH) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $20.33, Astrana Health, Inc. (ASTH) es una empresa del sector Healthcare valorada en 2B. La acción obtiene una puntuación de 60/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 9 feb 2026
Puntuación de IA de 60/100 Objetivo $34.00 (+67.2%) MCap 2B Vol 432K

Astrana Health, Inc. (ASTH) Resumen de Asistencia Médica y Tuberías

CEOBrandon K. Sim
Empleados1900
Sede CentralAlhambra, CA, US
Año de la oferta pública inicial (OPI)2009

Astrana Health (ASTH) is a physician-centric, technology-powered healthcare management company driving value-based care through its integrated platform. With a focus on care coordination and a growing network, Astrana Health is positioned to capitalize on the shift towards preventative, patient-centered healthcare, despite its current low profit margin of 0.3%.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 9 feb 2026

Tesis de Inversión

Astrana Health presents a notable research candidate due to its focus on value-based care and technology-driven healthcare management. The company's integrated platform and physician-centric approach are well-aligned with the industry's shift towards preventative and coordinated care. While the current P/E ratio is high at 108.83 and the profit margin is low at 0.3%, the company's strategic positioning and growth opportunities could drive future profitability. Key catalysts include expanding its care network, leveraging its technology platform for greater efficiency, and capitalizing on the growing demand for value-based care models. The company's beta of 0.89 suggests lower volatility compared to the market, making it a potentially noteworthy option for risk-averse investors seeking exposure to the healthcare sector.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $1.06 billion, reflecting investor confidence in Astrana Health's growth potential.
  • Operates through three segments: Care Partners, Care Delivery, and Care Enablement, providing a comprehensive suite of healthcare services.
  • P/E ratio of 108.83, indicating a premium valuation based on current earnings.
  • Gross margin of 10.1%, highlighting opportunities for improvement in operational efficiency.
  • Beta of 0.89, suggesting lower volatility compared to the overall market.

Competidores y Pares

Fortalezas

  • Proprietary technology platform for population health management.
  • Integrated value-based care model.
  • Established physician network.
  • Focus on care coordination services.

Debilidades

  • Low profit margin of 0.3%.
  • High P/E ratio of 108.83.
  • Reliance on insurance reimbursements.
  • Limited geographic diversification.

Catalizadores

  • Upcoming: Expansion of the care network to new geographic areas.
  • Ongoing: Continued development and integration of the technology platform.
  • Ongoing: Increasing adoption of value-based care models by payers and providers.
  • Upcoming: Potential strategic acquisitions to expand service offerings.
  • Ongoing: Positive results from clinical trials or research studies demonstrating the effectiveness of the company's care model.

Riesgos

  • Potential: Changes in healthcare regulations, such as the Affordable Care Act, could negatively impact the company's business.
  • Ongoing: Increased competition from other healthcare providers could erode market share and profitability.
  • Ongoing: Pressure from payers to reduce reimbursement rates could squeeze margins.
  • Potential: Economic downturn could reduce patient access to healthcare and negatively impact revenue.
  • Potential: Cybersecurity breaches or data privacy violations could damage the company's reputation and result in financial losses.

Oportunidades de crecimiento

  • Expanding Care Network: Astrana Health has the opportunity to expand its network of primary care physicians, specialist physicians, and extenders. By increasing its network coverage, the company can reach a larger patient population and drive revenue growth. The market for physician network expansion is significant, with the potential to capture a larger share of the healthcare market. Timeline: Ongoing.
  • Leveraging Technology Platform: Astrana Health's proprietary population health management and healthcare delivery platform offers significant growth opportunities. By further developing and integrating its technology, the company can improve care coordination, enhance patient engagement, and drive operational efficiencies. The market for healthcare technology solutions is rapidly growing, driven by the need for improved data analytics and patient management. Timeline: Ongoing.
  • Capitalizing on Value-Based Care: The shift towards value-based care models presents a major growth opportunity for Astrana Health. By demonstrating improved patient outcomes and cost savings, the company can attract more patients, physician groups, and health plans. The market for value-based care is expanding as healthcare providers and payers seek to improve quality and reduce costs. Timeline: Ongoing.
  • Strategic Acquisitions: Astrana Health can pursue strategic acquisitions to expand its geographic reach, enhance its service offerings, and gain access to new technologies. The market for healthcare acquisitions is active, with numerous opportunities to acquire complementary businesses. Timeline: Ongoing.
  • Expanding Service Offerings: Astrana Health can expand its service offerings to include additional healthcare services, such as telehealth, remote patient monitoring, and chronic disease management. By offering a broader range of services, the company can attract more patients and generate additional revenue streams. The market for these services is growing rapidly, driven by the increasing demand for convenient and accessible healthcare. Timeline: Ongoing.

Oportunidades

  • Expanding care network.
  • Capitalizing on the shift towards value-based care.
  • Strategic acquisitions.
  • Expanding service offerings.

Amenazas

  • Changes in healthcare regulations.
  • Increased competition from other healthcare providers.
  • Pressure from payers to reduce reimbursement rates.
  • Economic downturn affecting patient access to healthcare.

Ventajas competitivas

  • Proprietary Technology Platform: Astrana Health's population health management and healthcare delivery platform provides a competitive advantage by enabling efficient care coordination and data-driven decision-making.
  • Integrated Value-Based Care Model: The company's integrated model aligns incentives between providers and payers, leading to improved patient outcomes and cost savings.
  • Established Physician Network: Astrana Health's network of primary care physicians, specialists, and hospitalists provides a strong foundation for growth and expansion.
  • Care Coordination Services: Astrana Health's care coordination services differentiate it from competitors and enhance patient engagement.

Acerca de ASTH

Astrana Health, Inc., formerly known as Apollo Medical Holdings, Inc., was incorporated in 1985 and rebranded in February 2024, signaling a renewed focus on its mission. Headquartered in Alhambra, California, Astrana Health operates as a physician-centric, technology-powered healthcare management company. The company's core business revolves around providing medical care services within the United States. Astrana Health operates through three key segments: Care Partners, Care Delivery, and Care Enablement. These segments work synergistically to deliver a comprehensive suite of healthcare services. Astrana Health leverages its proprietary population health management and healthcare delivery platform to operate an integrated, value-based healthcare model. This model empowers providers within its network to deliver enhanced care to their patients. The company offers care coordination services, extending its reach to patients, families, primary care physicians, specialists, acute care hospitals, alternative inpatient care sites, physician groups, and health plans. Astrana Health's physician network comprises primary care physicians, specialist physicians and extenders, and hospitalists. The company serves a diverse patient base, primarily those covered by private or public insurance, including Medicare, Medicaid, and health maintenance organization plans, as well as non-insured patients. Astrana Health's commitment to technology and value-based care positions it as a key player in the evolving healthcare landscape.

Qué hacen

  • Provides medical care services in the United States.
  • Operates through three segments: Care Partners, Care Delivery, and Care Enablement.
  • Leverages a proprietary population health management and healthcare delivery platform.
  • Operates an integrated, value-based healthcare model.
  • Offers care coordination services to patients, families, and healthcare providers.
  • Manages a physician network consisting of primary care physicians, specialists, and hospitalists.
  • Serves patients covered by private or public insurance, as well as non-insured patients.

Modelo de Negocio

  • Generates revenue through providing medical care services to patients.
  • Receives payments from private and public insurance plans, including Medicare and Medicaid.
  • Contracts with health maintenance organizations (HMOs) to provide care to their members.
  • Offers care coordination services to healthcare providers and organizations.

Contexto de la Industria

Astrana Health operates within the medical care facilities industry, a segment experiencing growth driven by an aging population and increasing demand for healthcare services. The industry is undergoing a shift towards value-based care models, emphasizing preventative care and improved patient outcomes. Astrana Health's focus on technology and integrated care positions it favorably within this evolving landscape. Competitors include companies like Acadia Healthcare Company (ACHC), which operates behavioral healthcare facilities, and Addus HomeCare Corporation (AVAH), which provides home care services. The industry is characterized by increasing consolidation and a focus on efficiency and cost containment.

Clientes Clave

  • Patients covered by private insurance plans.
  • Patients covered by public insurance plans, such as Medicare and Medicaid.
  • Health maintenance organizations (HMOs).
  • Primary care physicians, specialist physicians, and hospitalists.
Confianza de la IA: 73% Actualizado: 9 feb 2026

Finanzas

Gráfico e información

Precio de la acción de Astrana Health, Inc. (ASTH): $20.33 (-0.58, -2.77%)

Últimas noticias

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ASTH.

Objetivos de Precios

Objetivo de consenso: $34.00

MoonshotScore

60/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de ASTH en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Preguntas Comunes Sobre ASTH

¿Cuáles son los factores clave para evaluar ASTH?

Astrana Health, Inc. (ASTH) actualmente tiene una puntuación IA de 60/100, indicando puntuación moderada. La acción cotiza a un P/E de 104.9x, por encima del promedio del S&P 500 (~20-25x), sugiriendo altas expectativas de crecimiento. Los analistas apuntan a $34.00 (+67% desde $20.33). Fortaleza clave: Proprietary technology platform for population health management.. Riesgo principal a monitorear: Potential: Changes in healthcare regulations, such as the Affordable Care Act, could negatively impact the company's business.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de ASTH?

ASTH actualmente puntúa 60/100 (Grado B) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de ASTH?

Los precios de ASTH se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre ASTH?

Los analistas han establecido un precio objetivo de consenso de $34.00 para ASTH, representando un potencial alcista del 67% desde el precio actual de $20.33. La cobertura incluye calificaciones de compra, mantener y venta, estimaciones de ganancias y recientes mejoras o rebajas. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en ASTH?

Las categorías de riesgo para ASTH incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Changes in healthcare regulations, such as the Affordable Care Act, could negatively impact the company's business.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Con un P/E de 104.9x, la acción conlleva un riesgo de valoración elevado si las expectativas de crecimiento no se cumplen. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de ASTH?

Astrana Health, Inc. (ASTH) tiene una relación P/E de 104.9, que está por encima del promedio del mercado, lo que puede indicar altas expectativas de crecimiento. La relación P/E compara el precio de la acción con sus ganancias por acción. Compare con el promedio del S&P 500 (~20-25x) para contexto. Esto no es asesoramiento financiero.

¿Está ASTH sobrevalorada o infravalorada?

Determinar si Astrana Health, Inc. (ASTH) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Su relación P/E es 104.9. Objetivo de analistas $34.00 (+67% desde el precio actual). Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de ASTH?

Astrana Health, Inc. (ASTH) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Information is based on available data and may be subject to change.
  • Investment decisions should be based on individual risk tolerance and financial circumstances.
Fuentes de datos

Popular Stocks